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ABSTRACT 
Background: Diabetic Retinopathy (DR) is an inflammatory disease mainly characterized 
by the dysfunction of the retinal blood vessels. Several studies reported a possible link 
between the hyperglycemia and the activation of unfolded protein response (UPR) and 
hence initiating endoplasmic reticulum (ER) stress in various retinal cells. However, the 
mechanism underlying the ERS in the human retinal endothelial cells (HRMEC) remains 
poorly investigated and understood.  
Methodology: In the present study, utilizing the HRMEC, we evaluated the effect of high 
glucose (30mM) on several ERS signaling pathway (HSPA5, EIF2K3, and XBP1) at the 
mRNA expression level; the inflammatory cytokines (NFkB) at the protein level; the 
adhesion molecules (ICAM-1 and E-selectin) by flowcytometry . Also, we assessed the 
barrier function of HRMEC on real-time analysis using the electric-cell substrate 
impedance (ECIS). Also, this study uses the Tunicamycin (TM) as positive stress inducer 
and Phenyl-butyric acid (PBA) as an ERS inhibitor and study their effects on the treatment 
groups.  
Results: We found that hyperglycemia increases the cellular production of reactive oxygen 
species (ROS) and PBA decreasing it. Also, the barrier quality of HRMEC was affected 
significantly by the treatment of high glucose and improved with PBA. The expression of 
Adhesion proteins (ICAM-1 and E-selectin) were increased in hyperglycemia and 
decreased expression with PBA.  
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Conclusion: Our results suggest that hyperglycemia may activate ERS that could play a 
role in the angiogenesis in the diabetic retinopathy. 
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1. Chapter One 
 
1.1 Introduction of the project: 
 
       Endoplasmic reticulum (ER) is an important component of the human cell. It consists 
of the cytoplasmic membrane- bound tubules. Under normal condition, it plays the main 
role in protein folding and synthesis. Under certain circumstances, acquisition of misfolded 
proteins occurs leading to ER stress (ERS) and activation of the unfolded protein response 
(UPR) (Sage et al., 2012).  ERS is correlated with several reported diseases like 
neurodegenerative diseases and diabetes mellitus. Several previous studies described ERS 
as a relevant factor for hyperglycemia, nephropathy, and atherosclerosis (Sage et al., 2012 
& Werstuck et.al, 2006). Many studies have focused on the molecular level of the UPR. 
Three main proteins have been identified following UPR stimulation in cellular stress. 
These proteins include; protein kinase RNA-like ER kinase pathway (PERK), the inositol-
requiring protein-1 (IRE-1), and activating transcription factor-6 (ATF-6) (Sage et al., 
2012). These proteins are attached to ER chaperone Glucose-regulated protein 78 (GRP78) 
(Werstuck et.al, 2006). In normal state, GRP78 keeps the compound inactive while 
undERS conditions the GRP78 will be dissociated from the three proteins and, as a result, 
several downstream genes been activated for cell maintenance or driving the cell to 
apoptosis (Harding et.al, 2005; Lee et. al, 2003& Haze et.al,1999). Another experimental 
study suggested that ERS also caused inflammation in animal models of diabetic 
retinopathy and found that the three UPR pathways and the inflammatory gene expressions 
are activated in the retinal endothelial cells (Ma, Wang &Zhang,2014;& Li et.al, 2009). 
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Also, chaperone-like activity, 4- phenylbutyrate acid (PBA) was reported to diminish the 
effect of ERS as well as the inflammation of the retina and vascular leakage in the diabetic 
animals. PBA is a terminal aromatic substituted fatty acid and is a histone deacetylase 
(HDAC) activity inhibitor (Memori et.al, 2012). In Diabetic retinopathy, the interruption 
of the blood-retinal barrier is contributed by hyperglycemia (Ehlrich et. al, 2010). 
Disruption of Tight junctions between endothelial cells leads inflammation and increase 
production of adhesion molecules (through increased expression of vascular endothelial 
growth factor (VEGF) such as intracellular adhesion molecules 1 (ICAM-1), occludin and 
zonula occludin 1(ZO-1).  
1.2 Hypothesis: 
 
The hypothesis of this study based on that hyperglycemia will induce ERS in retinal 
endothelial cells leading to vascular pathology changes such as barrier dysfunction in the 
microvascular retinal endothelial cells. 
1.3 Significance of the problem: 
 
The endothelium is considered an important structure for conserving vascular 
integrity and homeostasis. Earlier studies suggested that endothelial dysfunction was 
significantly associated with increase adhesion molecules production and weak 
intracellular junction. ERS exerts a fundamental role in the vascular retinal physiology 
through stimulation of multiple intracellular signaling cascades. Also, it leads to the main 
physiological impact in retinal endothelial cells such as apoptosis, inflammation, increased 
VEGF production, and ultimately blood retinal barrier (BRB) breakdown, retinal 
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neovascularization (NV), and neuronal degeneration. The vascular effects of chronic 
hyperglycemia have been reviewed in some different related diseases, including the 
diabetic retinopathy and macular edema. All these data could help in some understanding 
the ER pathway which could be involved in diabetic retinopathy pathogenesis and thus 
could help in DR management. 
1.4 Research Aims and objectives: 
 
 Hyperglycemia role on retinal cells and induction of ERS is not well understood, in 
this study we aimed:  
1. Assessment of the expression of ERS protein markers (HSPA5, EIF2AK3, and 
XBP1) and the impact on vascular endothelial cells of the retina ( oxidative stress, 
and apoptosis). 
2. Assessment of the impact on mediators involved in the angiogenesis such as such 
as the angiogenesis markers such as (VGEF), and the inflammatory mediators such 
as (NFkB). 
3. Determination of the effect and role of ERS in the permeability of the retinal barrier 
function in HRECs exposed to hyperglycemia with and without ERS blocker and 
elucidate molecules involved in it by utilizing the recent impedance technology as 
previously published using the Electrical Cell–Substrate Impedance Sensing 
(ECIS). 
4. Assessment of the adhesion molecules (ICAM and Selectin) by flow cytometry in 
reepsone to hyperglycemia with and without ERS blocker. 
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2. Chapter Two 
 
2.1 Biology of the endoplasmic reticulum: 
 
Endoplasmic reticulum (ER) is a complex cytoplasmic organelle in the human cell.  The 
first description of the ER was in 1945 by Porter, Claude, and Fullam who described it as 
“delicate lace-work extending throughout the cytoplasm” (Porter, Claude & Fullam,1945). 
It is composed of the cytoplasmic membrane-bound tubules. It is divided into two types; 
the rough ER (RER) and the smooth ER (SER). While ribosomes are embedded in the 
tubules of RER, SER tubules lacked it and only characterized by the smoothness of the 
tubules (Agostinis & Samali, 2012).  The proportion of RER to SER in all cells vary 
depending on the function. Both RER and SER are enriched with specific different proteins 
needed for specific ER functions (Chen et al., 2010). Although RER is enriched with 
proteins required for protein synthesis and SER are plentiful enriched differently with 
specific proteins for each cell type.  
ER have multiple vital roles. First; are the protein synthesis, processing, and folding. The 
ribosomes of the RER are controlling the synthesis of the soluble proteins, proteins for 
exports and membranous proteins. The oxidizing environment of RER is of favor and best 
for protein folding,  maturation, and disulfide bond formation.  
Also, Chaperones were reported in regulating the correct folding and protein assembly 
whereas enzymes assist in protein modifications which include N-linked glycosylation and 
disulfide bond formation. Furthermore, ER contains other regulators like the glucose-
regulator proteins (GRPs). These include Glucose-regulated protein 78 (GRP78) and 
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Glucose-regulated protein 94 (GRP94) (Lee, 2001). Both GRP78 and GRP94 are also 
assisting in protein folding by identifying and binding to the hydrophobic part of the 
peptide. However, GRP78 is the most abundant protein with multiple roles. It is involved 
in endoplasmic reticulum-associated folding (ERAF), endoplasmic reticulum-associated 
degradation (ERAD), recognition of faulty proteins folding, and inducing the unfolded 
protein response (UPR). These functions as a quality control step in ER. ERAD is a process 
where the misfolded proteins will be transferred to the cytoplasm for ubiquitination by the 
proteasome (Stolz and Wolf, 2010).   
2.2 Endoplasmic reticulum stress:  
 
2.2.1 Endoplasmic reticulum stress and unfolded protein response: 
 
ERS is a process caused mainly by a disruption in the protein folding and maturation 
process. Some of the main factors causing ERS are chemical disruption of ER function 
(e.g. glycosylation), metabolic conditions (e.g. increased glucose level), disturbance in the 
Ca+ homeostasis and mutations causing abnormality in some proteins or enzymes synthesis 
(Hampton et al., 2000). Glycosylation has an enormous role in the quality control as well 
as in monitoring the protein folding process and determination the fate of the protein 
direction either for further processing at Golgi apparatus or following ERAD process (Mori 
et al., 1992). Tunicamycin is a drug used in several trails, as an inhibitor for ER 
glycosylation and hence inducing ERS (Galan et al., 2014; Nakamura et al., 2013).  The 
cell responding to ERS through activation of ERS pathway and the induction of UPR to 
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maintain the cell homeostasis. This occurs through controlling protein translation, protein 
folding, ERAD, and autophagy (Ng, Spear, and Walter, 2000). 
2.2.2 ERS signaling pathway: 
 
During stress, UPR is arbitrated by three ER transmembrane sensors which eventually 
causing activation of series of transcription factors (Back & Kaufman, 2012). These 
sensors include; protein kinase RNA-like ER kinase (PERK), the inositol-requiring 
protein-1 (IRE-1), and activating transcription factor-6 (ATF-6) (Sage et.al, 2012). Those 
proteins are binding to GRP78 which is also known as heat shock 70kDa protein (HSPA5) 
(Werstuck et. al, 2006). In normal state, GRP78 keeps the compound inactive while 
undERS conditions the GRP78 will be dissociated from the three sensors and as a result, 
several downstream genes and transcription factors been activated for cell maintenance or 
driving the cell to apoptosis as described in figure 1 (Harding et.al,2000; Lee et. al, 2003; 
Haze et.al, 1999). The pro-apoptotic pathway is activated as soon as ERS prolonged and 
UPR fails to revert the cell to a normal state resulting in apoptosis, retinal inflammation 
and angiogenesis. 
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Figure 1: Endoplasmic Reticulum Stress signaling pathway. The three main sensors; ATF6, 
IRE1, and PERK,  are activated due to exposure of endoplasmic reticulum to stress conditions. 
Adopted from Waldron, Pandol, Lugea &Groblewski, 2015. 
 
 
2.2.2.1 ATF6 pathway: 
 
ATF6 is a specific transcription factor involved in the activation of the ERS pathway.  
The regulatory role of ERS and the involvement of ATF6 as part of this pathway is not 
understood and was investigated for more than a decade ago. In ERS conditions, ATF6 is 
converted from 90 kD (p90ATF6) protein to 50 kD (p50ATF6) by a proteolytic process. 
P50ATF6 tends to accumulate in the nucleus and hence activating the transcription of 
GRP78 in the ER (Haze et.al, 1999).  
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2.2.2.2 PERK pathway: 
 
UndERS conditions, the alpha subunit of eukaryotic initiation factor 2 (eIF2) is 
phosphorylated through certain protein kinases (Wek, Jiang & Anthony, 2006). The eIF2 
kinases increased activation during ERS is Pancreatic eIF2 α kinase (PEK) (Harding et al., 
2000; Kaufman, 2004). The eIF2 kinases involved in regulation of other pathways and 
resulted in blocking the protein translation and upregulating of the downstream gene that 
has an effect on the ERS pathway that leads to cell death. Activating transcription factor 4 
(ATF4) is one of the main players that is regulated by eIF2 in the PERK and it is responsible 
for redirecting protein translation and activation of the pro-apoptotic factors such as 
CCAAT/enhancer binding protein homologous protein (CHOP) and ATF3 (Wek, Jiang & 
Anthony, 2006), also described in figure 1. The mechanism of this pathway is not yet 
understood. 
2.2.2.3 X-box-binding protein 1 (XBP1 gene) 
XBP1 is a  transcription factor which also control UPR during ERS. XBP1 is required for 
the embryogenesis and the development of tissues such as exocrine pancreas and salivary 
gland. It modulates the cellular response to ERS in a PIK3R-dependent manner 
(PubMed:20348923). It is also involved in VEGF-induced endothelial cell (EC) 
proliferation and the retinal blood vessel formation during the embryonic development and 
the angiogenesis of adult tissues under ischemic conditions. One of the major functions 
also is working as a regulator of the UPR in obesity-induced insulin resistance and type 2 
diabetes (T2D) for the management of obesity and diabetes prevention. 
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2.3 Role of Endoplasmic reticulum stress in Apoptosis: 
 
Cellular apoptosis is a programmed cell death. This mechanism is activated due to several 
factors dependent or independent from the UPR pathway. MEKK (MAP3K) and 
reorganization of the ER membrane is one of the dependent factors and the PERK, and 
IRE1/XBP1 pathway was recognized as independent factors for apoptosis following 
prolonged ERS (Sano and Reed, 2015). In PERK pathway, a multifunctional transcription 
factor CHOP plays a vital role in both cell apoptosis and cell survival (Nishitoh, 2011). 
Although the CHOP activation leading to apoptosis is not clear, many studies suggested 
different models. According to, Fu et al., 2010, model; activation of   CHOP causes down-
regulation of the antiapoptotic BcL2 genes which lead to cell apoptosis. Under certain 
cellular stress, phosphorylation of CHOP by P-38 Mitogen-activated Protein Kinase (P38-
MAPK) leads to apoptosis. This mechanism is activated as an effect of IRE1/XBP1 
activation through TNF-Receptor Associated Factor (TRAF2) which mediate the 
activation of apoptosis signal-regulating Kinase 1(ASK1). ASK1, in turn, activate both C-
Jun Amino Kinase (JNK) and P38-MAPK (Figure 1). Suggested models deficient of XBP1 
induced oxidative stress, inflammation and cell death (Jing, Wang, Zhang;2012). Several 
genes which are controlled by CHOP such as GADD34 are causing induction of reactive 
oxygen species (ROS) (Kojima, 2003; Han et al., 2013). Also, genes activating CHOP such 
as ATF4, have been reported to induce ROS in the ER lumen and caused apoptosis 
(Tavender et al. 2010). 
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2.4 Role of Endoplasmic reticulum in oxidative stress: 
 
Production of ROS is a crucial process for maintaining the hemostasis in normal cell 
conditions. The cellular production of ROS comes from different sources. It originates 
from the ER during the formation of the disulfide bonds and from the mitochondria during 
the mitochondrial respiration or detoxification. In the ER, the process of disulfide bond 
formation which occur as part of protein folding is mediated by enzymes like protein 
disulfide isomerase (PDI) and other chaperones like ERp72 and ERp57. Due to the nature 
of this process inside ER, the ER environment is considered highly oxidized, and the 
glutathione (GSH) will be catalyzed into glutathione disulfide (GSSH) (Hwang et al., 
1992). The GSH is an essential antioxidant element.   On the other hand, protein misfolding 
in ER increase the formation of ROS over the normal limit causing oxidative stress. When 
ROS accumulate in ER, it affects the Ca+ hemostasis causing Ca+ to escape from ER lumen. 
UPR will be activated, and persistent ERS will activate the pre-apoptotic pathway 
(Malhotra & Kaufman, 2007). Another possible linking mechanism of ERS pathway and 
ROS production is activated by increased level of blood sugar or hyperglycemia. 
Hyperglycemia could cause activation of the ERS signaling as a result of diabetic 
retinopathy. 
2.5  Endoplasmic Reticulum Stress and Diabetic Retinopathy: 
 
Diabetes is a chronic illness mainly distinguished by hyperglycemia. Diabetes eventually 
leads to several complications such as macular edema, renal failure, cardiovascular 
diseases and Diabetic Retinopathy (DR). DR is a disease marked by loss of the blood 
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vessels. This leads to retinal ischemia and after that retinal neovascularization. Moreover, 
the breakdown of the blood-retinal barrier (BRB) is another feature of DR. During BRB 
breakdown, the tight junction molecules between the endothelial cells loosen and break 
down (Ma, Wang &Zhang; 2014). 
Different molecular pathogenic mechanisms had been identified and caused ERS pathway 
activation. Molecular changes in both obesity and diabetes cause activation of the ERS 
pathway and leads to DR. Many studies reported that certain genes play a protective role 
against developing DR. This is causing the variety in the occurrence and the disease 
severity from one patient to another (Hu et.al, 2012). However, other genes are reported to 
be up-regulated in different cell types studies related to the retinal vascular damage and 
neovascularization; activating ATF4 and VEGF (Roybal et. al, 2004 and Abcouwer et.al, 
2002).  
2.6 Hyperglycemia and Blood Retinal Barrier Function: 
 
BRB have a crucial role in the retina. It keeps the fluid control with the presence of another 
important protein which is the tight junctions (TJ) proteins. BRB also maintain the retinal 
endothelial cells integrity and polarity. BRB is divided into the inner part and the outer 
part. The inner part consists of retinal capillary endothelial cells whereas the outer part 
consists of retinal pigment epithelial (RPE) cells. Both the internal and external parts share 
a similarity in that these cells are linked together by TJ proteins. The most studied TJ are; 
occludin, claudin and zonula occluding (ZO-1) (Bauer et al., 2011).  
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Studies reported that BRB disruption is a leading cause of diabetic macular edema. RPE 
cell lines, when exposed to hyperglycemic conditions and increase IL1B, showed alteration 
in claudin-1 which suggests that there is a general alteration in the TJ organization (Trudea 
et al., 2011). However, RPE cell lines are previously known for demonstrating 
heterogeneity (reviewed by Goncalves, Ambrosio & Fernandes; 2013). Also, pro-
inflammatory cytokines like VEGF was reported to arbitrate permeability in HRMEC 
during ERS (Li et al., 2009). Knowledge is still lacking how the exact role of ERS in BRB. 
In this study, we utilized HRMEC exposed to hyperglycemia and ERS blocker to contribute 
some mechanisms understanding. 
  
 
3. Chapter Three 
3.1 Materials: 
 
Primary HRMEC; reference number ACBRI 18 were purchased from Cell System as 
passage 3. Complete CSC medium kit accompanied with serum and culture boost (4Z0-
500), Complete Serum-Free Medium Kit accompanied with Rocket Fuel (SF-4Z0-500-R), 
CSC Attachment factor™ (4Z0-210), CSC Passage Reagents Group™ (4Z0-800), Bac-
off® (4Z0-643), and CSC Cell Freezing Medium (4Z0-705) all were purchased from Cell 
System, 12815 NE 124th Street, Suite A Kirkland, WA 98034. These items are summarized 
in the following table.  
 
 
Table 1. Cell culture reagents and cell lines required for this study. All items were 
purchased from Cell-System (USA). 
Item Cat # 
Cryopreserved human retinal microvascular endothelial cells 
(HRMEC) 
ACBRI 181 
Passage Reagents Group 4Z0-800 
Complete CSC Classic Medium: with 10% serum and culture 
boost 
4Z0-500 
Complete Serum-Free Medium Kit: with Rocket Fuel SF-4Z0-500-R 
Attachment Factor 4Z0-210 
Bac-off (antibiotic) 4Z0-643 
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Chemical used generally in most of the experiments include; D-Glucose (G7021), D-  
Mannitol (M4125), Phosphate Buffered Saline (PBS) pH 7.4,10X (70011036) were 
purchased from Gibco (Life Technologies, UK), Chloroform 277105X purchased from 
BDH, and Ethanol 96% (20823.327) purchased from VWR (Radnor, PA 19087-8660, 
USA). The following table shows a list of these reagents. 
 
 
Table 2: List of Chemicals and Reagents.  
Item Manufacturer Cat # 
D-Glucose Sigma - Aldrich G7021 
D-Mannitol   Sigma-Aldrich M4125 
Phosphate Buffered Saline 
(PBS) pH 7.4 (10X) 
Gibco (Life Technologies, UK) 70011036 
Chloroform BDH 277105X 
Ethanol 96% VWR 20823.327 
Tunicamycin Santa Cruz Sc-3506A 
4-Phenyl butyric acid  Santa Cruz Sc-232961 
 
 
Also, Tali® Image-Based Cytometer reagents include Tali® Apoptosis Kit - Annexin V 
Alexa Fluor® 488 &Propidium Iodide (A10788), and CellRox® Oxidative stress reagent 
(C10443) were obtained from Life Technologies USA. As shown in the following table. 
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Table 3 List of Tali-Image based Cytometer Reagents. 
Item Manufacturer Cat # 
Tali® Apoptosis Kit - Annexin V Alexa 
Fluor® 488 &Propidium Iodide 
Life Technologies USA A10788 
CellRox® Oxidative stress reagent Life Technologies USA C10443 
Tali® Cell Cycle Kit Life Technologies USA A10798 
 
 
TRIzol Reagent Ambion RNA (15596026) was purchased from Life Technologies (5791 
Van Allen Way, Carlsbad, California 92008, USA), High Capacity RNA-to-cDNA kit (P/N 
4387406) and TaqMan Gene Expression Master Mix (P/N 4369016) were purchased from 
Applied Biosystems (5791 Van Allen Way, Carlsbad, California 92008, USA). Listed in 
table 4. 
 
 
Table 4 List of Gene Expression Reagents. 
Item Manufacturer Cat # 
TRIzol Reagent Ambion RNA Life Technologies (USA) 15596026 
High Capacity RNA-to-cDNA kit Applied Biosystems P/N 4387406 
TaqMan Gene Expression Master Mix Applied Biosystems P/N 4369016 
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3.2 Methods: 
3.2.1 Human Retinal Endothelial Cell Culture: 
 
Cryopreserved HRMEC were used for experiments between passage 5 and 6. Passage 3 
cells were grown at 37 ⁰C in 5% CO2 in Tissue culture flasks (T75 cm2). HRMEC were 
treated with 2 to 3 mL of the attachment factor, and a Complete Serum medium (CSC) was 
added to the flask. Then, HRMEC were grown in T75cm2 and passaged using the Passage 
reagent Group. The attachment factor was used to enhance the cell growth and to support 
the polarity and cytoskeletal structure. CSC complete medium is composed of 10% serum, 
Dulbecco’s Modified Eagle Medium (DMEM/F12), normal human blood glucose level 
(concentration of 0.9008 g/L) and was supplemented with the combination of animal-
derived growth factors (Culture Boost) and an antibiotic treatment (Bac-Off® Tonic). The 
antibiotic is fluoroquinone ciprofloxacin.  
For all experiments, HRMEC has seeded in either 100 mm or 6 well plates. The culture 
medium was changed after the first 24 hr and then every 48 hr as needed. At 70-80% cell 
confluency, cells were kept in starvation status for 6-8 h. Starvation was achieved by 
adding 6 mL of the serum-free medium.  After the starvation, the drug treatment is added, 
and cells were kept in the treatment for the period designed in the plan. 
3.2.2 Treatment Protocol: 
 
During the pilot study, five groups of treatments at different time points were investigated. 
First, the untreated group (control) was representing the normal D-glucose concentration 
of 5 mM for 24 hr exposure. Second, Tunicamycin (0.1 µg/mL) was representing the 
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positive chemical ER inducer group for 24 hr exposure. Third, the treated group was 
represented with one high glucose concentration (30 mM) and observed at different 
exposure times; 24 hr, 48 hr, and 72 hr. Fourth, glucose oscillation group was observed for 
72 hr starting from 30 mM glucose then changing to 5 mM after 24 hr and finally to 30 
mM after 72 hr. Fifth, D-mannitol (30 mM) representing the osmotic control group with 
similar concentration and times as the third group of D-glucose. The following flowchart 
(figure 2) summarizes the treatment plan. 
 
 
 
Figure 2. Work plan for the pilot study treatment groups. Different exposure times (24, 48 and 
48hr) were performed for the glucose concentration of 30mM and the osmotic control group. 
 
 18 
 
During the experimental study, four groups were used. These groups were further sub-
grouped accordingly, as shown in the following workflow in figure 3.  First, group (A) 
represented the untreated (control) group of D-glucose concentration of 5 mM for 24 hr. 
Second, the group (B) represented the positive control of 0.1µg/mL Tunicamycin (TM) for 
exposure of 24 hr. Third, group (C) represented the high glucose concentration treatment 
(30 mM) and were sub-grouped into (C1) and (C2). Subgroup C1 treated with high glucose 
for 24 hr whereas subgroup C2 was treated for 48 hr.   Fourth, group D represented the 
addition of ERS blocker which is 4-phenylbutyric acid (PBA) and was sub-grouped to into 
(D1), (D2) and (D3). In all subgroups, PBA was added half an hour before the treatment 
with either TM or Glucose(Humeres et al., 2013). 
 
 
 
Figure 3. Work plan for the experiment study treatment groups. HREC were exposed to high 
glucose for 24 and 48 hrs. Additional groups of HREC exposed to high glucose 30mM and 4-
phenylbutyric acid (PBA) were added. 
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3.2.3 Cell Growth Parameters Protocols: 
3.2.3.1 Cell Count: 
 
Cell count was performed routinely before each culture/subculture either manually or using 
the Tali® image-based Cytometer application for quick cell count. The manual method 
was conducted before the HRMEC seeding.  A small quantity of the harvested cells (25 
µL) were mixed with equal amount of Trypan blue (25 µL) to get 1:1 dilution. The 
suspension was then added to the hemocytometer chamber and let to stand for 5 min.  The 
cells in the four corners and middle square were counted, and the average was calculated. 
The final count of cells have been computed as follow: 
Cells count/ 1mL= Average square count x Dilution Factor x 104  
Total cells count= Cells in 1mL x sample volume 
For the automated cell count method, which was performed before the experimental tests, 
25µL of the cell suspension was added to the Tali® analysis slide and loaded into the 
instrument for analysis. 
3.2.3.2 Cell Viability and Apoptosis: 
 
Apoptosis Kit was used to studying the apoptosis. The  Apoptosis Kit contains both a 
green-fluorescent Annexin V–Alexa Fluor® 488 conjugate and red-fluorescent PI. The 
first is used to identify the apoptotic cells whereas used to determine the necrotic cells. The 
recommended concentration is 100000 to 10000000 cells/mL.  HRMEC were harvested 
using 1 mL of trypsin-EDTA 0.25% followed by incubation for up to 7 min at 37⁰C. First, 
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staining of the cells was performed with 1x Annexin binding buffer (ABB) and Annexin V 
Alexa Fluor® 488 in a microcentrifuge tube. Second, the stained mixture was kept in the 
dark for 20 min followed by suspending in 1x ABB and PI. After that, the cells were kept 
for short incubation for 5 min and sample cells were ready for analysis. Finally, 25 µL of 
cells were loaded into the analysis slide and loaded into the instrument. The wavelength 
reading for Annexin V is 488/499 nm and for PI is 535/617 nm. 
3.2.3.3 Reactive Oxygen Species (ROS) measurements: 
 
ROS were evaluated using the Cell-ROX® Oxidative Stress reagent kit. First, HRMEC 
were harvested using 1 mL of trypsin-EDTA 0.25 % followed by incubation for up to 7 
min at 37⁰C. Then, the cells were suspended in 1x PBS and stained with 5µM of Cell-
ROX® orange reagent. This is followed by incubation of the mixture in the dark for 20 
min. After that, cells were washed 4 to 5 times with 1X PBS. Finally, 25 µL of cells loaded 
into the analysis slide and loaded into the Tali® Image-Based Cytometer. The Readings 
were recorded at 545/565 nm wavelength.  
3.2.4 Gene Expression Analysis: 
3.2.4.1 Extraction of RNA 
 
TRIzol® reagent was used to purify total RNA from each treatment group using. A slight 
modification was made to the kit instructions to enhance the concentration of RNA and 
improve the RNA purity. In brief, treated cells were homogenized with 1 mL TRIzol® 
reagent for 6 well plates and 3 mL for 100 mm plates. Cells were lysed and harvested using 
cell scrapers. Next, 0.2 mL of chloroform was added to the homogenized cells and 
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vigorously shaken by hand for 15 sec. The tube was kept for 5 min on ice and centrifuged 
at 12000 x g for 10 min at 4⁰C. The upper aqueous phase was collected as it contains total 
RNA. After that, 0.5 mL of 100% isopropanol was added to the collected aqueous phase 
for RNA precipitation. The tube was inverted several times gently and incubated for 10 
min on ice, followed by centrifuge of the mixture at 12000 x g for 15 minutes at 4⁰C. 
Moreover, the supernatant was removed, and 1 mL of 75% ethanol was added per 1mL 
TRIzol® reagent for RNA washing. Gentle inversion of the tube is recommended followed 
by centrifugation for 5 min 4⁰C. After removing the supernatant, an additional step of RNA 
washing was done. The pellet was kept at room temperature for maximum 10 min drying. 
Finally, the RNA pellet was resuspended in 20 µL RNase-free water and incubated at 56⁰C 
for 10 min.  
3.2.4.2 RNA concentration measurement: 
 
RNA purity was estimated by calculating the 260/280 nm absorbance ratio using the 
Nanodrop 2000 spectrophotometer instrument. First, the instrument software was set to the 
type of nucleic acid to be measured which are RNA-40. The concentration unit for the 
nucleic acid measurements was set also set to ng/µL.  After that, a default wavelength of 
340 nm was used by the instrument for normalization using dH2O. Then, a blank was 
established using the RNA suspension solution by pipetting 2 µL of the RNase-free water. 
Sample identification was entered in the appropriate field. Next, 2 µL of the RNA sample 
was loaded to the nanodrop, and concentration was recorded.  
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3.2.4.3 cDNA preparation: 
 
Only up to 2 µg of total RNA was quantitatively reverse transcribed into complementary 
DNA (cDNA)  using “High Capacity RNA to cDNA” kit. This resulted in synthesizing a 
single-stranded DNA. The procedure to synthesize cDNA was as follow. First, components 
of kits were thawed on ice before use. Next, the reaction mix was prepared by adding; 10 
µL of 2X RT buffer, 1 µL of 20X RT Enzyme Mix into an Eppendorf tube. Then, up to 2 
µg of total RNA was added and not to exceed the 9 µL (Table 5). Finally, the reaction as 
added to PCR thermocycler with a program as follow; the first step in 37 ⁰C for 60 min 
and another second step in 95 ⁰C for 5 min. 
 
 
Table 5. RT-PCR reaction mix and cDNA synthesis. 
Component Volume/Reaction (µL) 
2X RT buffer 10 
20X RT Enzyme Mix 1 
Nuclease-free water Quantity sufficient to complete reaction volume 
RNA sample up to 2 µg 
Total Reaction Volume 20 
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3.2.4.4 Real-time PCR analysis: 
 
The expression of mRNA level of ERS genes performed by quantitative PCR (qPCR) with 
different oligonucleotides sense and anti-sense primers. The ERS genes selected for the 
study are HSPA5, EIF2AK3, and XBP1. Also, the samples were quantified for VEGFA 
and  NFKB. The oligonucleotides used are listed in Table 6. cDNA prepared were ready to 
carry out the quantitative Real Time-PCR in Quanta Studio Flex6 thermal cycler 
instrument. The PCR reactions were prepared as in Table 7. PCR Reactions were run in 
duplicate and triplicate using  GeneAmp PCR System 9700 (Applied Biosystems). Target 
genes were analyzed using delta-delta (∆∆Ct) application and results were normalized to 
the endogenous control (β-Actin).  
 
 
Table 6 List of Oligonucleotides Probes. 
Gene Symbol Reference Sequence Company 
HSPA5 NM_005347 Life Technologies 
EIF2AK3 NM_004836(1) Life Technologies 
XBP1 NM_005080(2) Life Technologies 
VEGFA Hs.PT.56a.1149801.g IDT 
NFkB Hs.PT.58.21008943 IDT 
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Table 7. qPCR Reaction Mix. 
Component Volume/Reaction (µL) 
20x Primer/Probe 0.5 
2x TaqMan Master Mix 5 
cDNA 2 
Nuclease-free water 2.5 
Total Reaction Volume 10 
 
 
3.2.5 Analysis of Barrier Function by Electric Cell-Substrate Impedance Sensing 
(ECIS): 
  
HRMEC behavior quantification was detected by the electric cell-substrate impedance 
sensing (ECIS from Applied BioPhysics, USA) which is considered as a functional as well 
as an impedance based cellular assay. HRMEC were grown in a special chamber of eight 
wells. Each well coated with 10 gold electrodes. While HRMEC were growing and 
proliferated, an electrical current applied between the electrodes. The resulting potential is 
measured and calculated. HRMEC cell membrane will create resistance against the 
electrode current representing the study of the cell barrier function and attachment. The 
procedure for ECIS was carried out as in the manufacturer’s operation manual. First, 200 
µL of the attachment factor was added to the array wells. Second, after discarding the 
attachment factor 200µL of cold 10mM L-Cysteine was added and incubated for 15 min at 
room temperature. Cysteine works in providing reproducible capacitance to the 
experiment. Then, 200 µL of CSC complete serum medium was added to the 8 wells of the 
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array without adding any cells. After that, software was checked for electrode connectivity 
to each well. When all electrodes are connected, the instrument was started to collect data 
for free cells for 1 to 2 hr. Then, software was paused, and arrays were removed from the 
incubator to inoculate approximately 60.000 cells / well.  Cells in the array were checked 
under the microscope for proper dispersion. Run was resumed until cells grow to 80% 
confluency (16 to 24 hr). Connectivity of the electrodes of the array was checked every 
time the array and the run were stopped. After cells had reached 80% confluency, the CSC 
medium was discarded, and 200 µL of serum-free medium was added to the wells. The 
array was inserted back into the incubator, and run was resumed for 8 hours. After 8 hr, the 
serum-free medium was discarded, and the specified treatments for each well were added 
to the time as in the work plan. Finally, when the run was completed, the data analysis was 
carried out through the ECIS ZӨ software (Applied Biophysics). 
3.2.6 Adhesion molecules by Flowcytometer: 
 
Expression of adhesion proteins  CD56 (ICAM-1) and CD62E (E-selectin) on HRMEC 
was detected by BD® Accuri Flowcytometer. Generally, 500 µL of HRMEC groups 
resuspended in 1x PBS and then stained with 20 µL of PE Mouse anti-Human CD62E and 
PE Mouse anti-Human CD54. The suspensions were kept in the dark for 20 min and after 
that washed twice with 1x PBS. Analysis performed using BD® Accuri C6 software with 
minimum 20000 events. Unstained control was used to create the gating of cells based on 
cell granularity and cell size. 
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3.2.7 Statistical Analysis: 
 
The analysis of continuous data that were normally distributed was presented as mean 
±SD, for each experiment performed in triplicated for at least 2 times. Then tested by a 
one-way analysis of variance (ANOVA) then by post hoc for multiple comparison tests. 
A two-tailed P value was calculated, and results were considered significant for p value < 
0.05. All statistical analysis were performed using Graph Pad Prism version 7
  
 
4. Chapter Four 
 
To reach our goal, we utilized HRMEC exposed to hyperglycemia and ERS blocker.  
4.1 HMREC cells morphology: 
 
The outcome of hyperglycemia concentration (30 mM) on HMREC in all treatment groups 
was monitored for growth and morphology. The untreated cells were normally grown and 
reached 70% confluency after 48hr. Tunicamycin (positive control) showed same cell 
morphology and growth confluency as the normal non-treated cells. Mannitol was used as 
an osmotic control with a concentration similar to the treatment groups used (5 mM and 30 
mM), no differences were noticed in the cell morphology compared to the normal cells. 
The cell monitoring was obtained using the inverted microscope (10 X lens) and 
observations were recorded. Figure 4 shows the stages of HMREC growth and proliferation 
from 24 hr to the day of harvesting also it is indicating a comparison in cell count following 
each treatment.  Although the morphology of the cells of the different treated groups was 
similar, the cell count at certain time points showed minimal differences, which requered 
further investigation. 
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Figure 4.stages of HMREC growth and proliferation. A. HMREC after 24 hours of seeding. B. 
HMREC at confluency 70-80%. C. Untreated Control group (5.5mM glucose) at the time of cells 
harvesting. D. Positive Control group (Tunicamycin 0.1µg/mL) at the time of cells harvesting. E. 
Osmotic Control group (5.5mM Mannitol) at the time of cells harvesting. F. High glucose group 
(30 mM of D-glucose at 24 hours) at the time of cells harvesting. 
 
 
4.2 Cell Growth Parameters:   
4.2.1 Cell Count 
 
The cell count for all treated cells was performed before each experiment using Tali® 
Image-based Cytometer Quick Count application to ensure equal seeding cell number. Cell 
number was recorded following each treatment at harvesting time. The cell count showed 
that the average cell concentration was 1.1 x 106 cells/mL to 2.5 x 106 cells/mL. The average 
cell size also measured by Tali® Image-based Cytometer was 9 µm. This results exhibited 
a higher number of cell counts of the non-treated cells and TM-treated cells (2X) which 
require investigation of cell death and viability in other treated cells including high glucose 
group.   
B
Zoom in
A
10 XZoom in
after 24 At 70% confluency
Zoom in
Zoom in
10 X
10 X
C
D
Untreated Control
Positive Control 
10 X10 X
Osmotic Control High glucose 
Zoom in Zoom in
E
F
10 X
 29 
 
4.2.2 Effect of Hyperglycemia on Cell Viability: 
Assessment of the cellular viability is necessary to study the cytotoxicity of the chemical 
used on HRMEC.  Tali® Image-based Cytometer affording a method to quantify both the 
live and dead cells population. Dead cells showed red staining as PI dye was used and the 
cells undergo apoptosis, or apoptotic cells showed green staining due to Annexin V 
binding. 
The evaluation of the percentage of live cell populations revealed that HRMEC treated 
with high glucose following 24 hr exhibited a non-significant increase in comparison to 
normoglycemia group (p>0.999). Also, the addition of the ERS blocker PBA exhibited a 
non-significant change in the percentage of living cells (p>0.999). The remaining of 
HRMEC treatment groups shows an insignificant reduction in the percentage of live cells 
in compared to the normoglycemic group. Figure 5 illustrates the % of living cells in each 
treated group. 
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Figure 5. Effect of high glucose treatment for 24 and 48 hours measured by the percentage of Live 
Cells. Data are presented as means ±SD of 2-3 independent experiments analyzed by ANOVA with 
a post-hoc test for multiple experiments. The two-tailed p-value is significant at p ˂ 0.05. 
Abbreviations, normoglycemic cells (NG Ctrl); Tunicamycin-treated cells (Pos Ctrl); 
Tunicamycin-treated cells and ER blocker (Pos+B); High Glucose for 24 hours (HG24); High 
Glucose for 24 hours+ER blocker (HG24+B); High Glucose for 48 hours (HG48); and High 
Glucose for 48 hours+ER blocker (HG48+B)  
 
 
4.2.2 Effect of Hyperglycemia on HMREC on Apoptosis: 
  
Apoptosis assay was used to detect the apoptotic percentage induced by the effect of high 
glucose treatment in the HMREC and ERS. The assay was performed by Tali Apoptosis 
Kit- Annexin V Alexa Flour® 488 and PI. HRMEC treated with TM revealed a significant 
increase (p < 0.0001) in apoptosis rate by 7.12 fold compared to the HRMEC with 
normoglycemia (2.667± 1.528 VS 19±8.458) respectively. HRMEC treated with high 
glucose treatment for 24 and 48 hr revealed a non-significant increase in the apoptosis rate 
in comparison to normoglycemia group (14.25± 3.182 and 11.33± 3.512) respectively. 
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Following addition of the ERS blocker PBA to HRMEC treated with TM, it showed a 
significant reduction in the apoptosis rate by 11.8 fold compared to HRMEC treated with 
TM (p < 0.0001). The addition of the same blocker to HRMEC treated with high glucose 
for 24 and 48 hr showed a significant decrease by 9.3 and 2.5 folds for both group with 
(p=0.0001), respectively as illustrated in figure 6.  
 
 
 
Figure 6. Effect of high glucose (30mM) and Tunicamycin (0.1µg/mL) on Apoptosis. Bars shows the data 
presented as Mean ±SD of 2-3 independent experiments analyzed by one-way ANOVA with a post-hoc test 
for multiple comparison tests. The two-tailed P- value is significant at p ≤0.05. * p≤0.05 versus the untreated 
control group, **p≤0.0001 compared with blocked Tunicamycin group, *** p≤0.0001 compared HG24+B 
and HG48+B groups with their respective HG24 and HG48 groups. Abbreviations, normoglycemic cells (NG 
Ctrl); Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells and ER blocker (Pos+B); High 
Glucose for 24 hours (HG24); High Glucose for 24 hours+ER blocker (HG24+B); High Glucose for 48 hours 
(HG48); and High Glucose for 48 hours+ER blocker (HG48+B). 
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4.2.3 Effect of Hyperglycemia on oxidative stress: 
 
To study the oxidative stress quantitatively in HMREC exposed to high glucose (24 and 
48 hr), the percentage of the production of ROS was assessed by Tali® CellRox® 
Oxidative Stress reagent Kit using the Tali Image-based Cytometer. The total ROS 
production exhibited a significant increase in HMREC exposed to 0.1µg/mL TM by 12.6 
fold compared to HRMEC normoglycemia cells (p =0.0001). On the other hand, the 
addition of the blocker PBA to the HMREC treated with 0.1 µg/mL TM displayed a 
significant reduction in ROS by 2.9 folds (p=0.0476). Similarly, ROS produced by 
HRMEC treated with 30mM high glucose at 24 hr and 48 hr showed a significant increase 
of by 29.9 and 7.5 folds in comparison to HRMEC with normoglycemia (both p<0.0001). 
The addition of blocker PBA to the HRMEC treated with high glucose groups (30 mM for 
24 and 48 hr) displayed a significant reduction by 14.3 and 13.8 folds compared to the 
hyperglycemic HMREC cells at 24hr and 48hr  respectively (p=0.0001) (figure 7). 
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Figure 7. Effect of high glucose (30mM) treated for 24 and 48 hours and Tunicamycin (0.1µg/mL) 
on the production of reactive oxygen species in HMREC. Bars shows the data presented as Means 
±SEM of 2-3  independent experiments analyzed by one-way ANOVA and post-hoc multiple 
comparison tests. P value is significant at p≤0.05. * p≤0.05 versus the untreated control group, ** 
p≤0.05 compared with Tunicamycin blocked by PBA group, α p≤0.05 compared with high glucose 
group blocked with PBA (30mM for 24 hours) and δ p≤0.05  compared with high glucose group 
blocked with PBA (30mM for 48 hours). Abbreviations, normoglycemic cells (NG Ctrl); 
Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells and ER blocker (Pos+B); High 
Glucose for 24 hours (HG24); High Glucose for 24 hours+ER blocker (HG24+B); High Glucose 
for 48 hours (HG48); and High Glucose for 48 hours+ER blocker (HG48+B). 
 
 
4.2.4 Gene Expression Analysis of ERS pathway, NFkB, and VEFA: 
 
To study the effect of high glucose and TM treatment on HRMEC, gene expression of 
HSPA5, EIF2AK3, and XBP1 genes were examined and normalized to the β-actin 
R
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housekeeping gene. First, Total RNA was extracted from HRMEC study groups, and 
concentrations and purity were recorded as shown in the following table. 
 
 
Table 8. RNA Concentration and Purity. 
Treatment Group 
RNA Concentration 
(ng/µL) 
Purity 
(290/280) 
Untreated- Normoglycemia 2001 2.1 
Positive Control- TM 1299 2.13 
TM+ PBA 1259 2.13 
HG24 hours 951 2.08 
HG24 +PBA 759 2.08 
HG48 hours 1073 2.1 
HG48+ PBA 1056 2.08 
 
 
Expression analysis of HSPA5 mRNA in HRMEC exposed high glucose 30 mM (24), and 
TM revealed significance change in the expression levels normalized to the normoglycemia 
group. High glucose 24 hours showed a significant increase (p=0.0219) by approximately 
2 folds compared to normoglycemia group whereas high glucose 48 hours showed an 
insignificant increase (p=0.452) compared to the normoglycemic group. Notably, the 
addition of  ERS blocker PBA decreased the level of the HSPA5 expression significantly 
in each treatment group. In HRMEC with TM and PBA, the reduction was significant (p= 
0.0014) by 1.8 folds compared with HRMEC with TM only. In HRMEC of high glucose 
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24 and 48 hr with PBA, the reduction was significant (p= 0.0039 and p= 0.045) by 3.6 and 
3.5 folds respectively (figure 8). 
 
 
 
Figure 8.Effect of high glucose (30mM) and Tunicamycin (0.1µg/mL) on HSPA5 gene expression. 
Bars shows the data presented as Mean ±SEM of 2-3 independent experiments analyzed by one-
way ANOVA with a post-hoc test for multiple comparison tests. The two-tailed P- value is 
significant at p ≤0.05. * p≤0.05 versus the untreated control group, δp≤0.05 compared with blocked 
Tunicamycin group, α p≤0.05 compared with high glucose 24 hours. Abbreviations, 
normoglycemic cells (NG Ctrl); Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells 
with ERS blocker PBA (Pos+B); High glucose treated cells for 24 hours (HG24); High glucose 
treated cells for 24 hrs with PBA (HG24+B); High glucose treated cells for 48 hrs (HG48); High 
glucose treated cells for 48 hrs with PBA (HG48+B). 
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Similar to HSPA5, the expression analysis EIF2K3 in HRMEC exposed to high glucose 
(24 hr) and TM revealed significance change in the expression level normalized to the 
normoglycemia group. HRMEC treated with TM showed a significant increase (P=0.0001) 
in EIF2AK2 expression by 4 folds compared to the normoglycemia group.  Also, HRMEC 
of high glucose 24 hr showed a significant increase (p=0.005) by 3.1 folds compared to the 
normoglycemic group. Furthermore, HRMEC with TM and ERS blocker PBA decreased 
significantly the level of the  EIF2AK2 expression (p=0.0027) by 2.7 folds compared 
HRMEC  with TM only. In HRMEC of high glucose 24 with PBA, the reduction was 
significant (p= 0.0012) by 2.6 folds compared to HRMEC with high glucose only (figure 
9). 
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Figure 9. Effect of high glucose (30mM) and Tunicamycin (0.1µg/mL) on EIF2AK3 gene 
expression. Bars shows the data presented as Mean ±SEM of 2-3 independent experiments analyzed 
by one-way ANOVA with a post-hoc test for multiple comparison tests. The two-tailed P- value is 
significant at p ≤0.05. * p≤0.05 versus the untreated control group, δp≤0.05 compared with blocked 
Tunicamycin group, α p≤0.05 compared with high glucose 24 hours. Abbreviations, 
normoglycemic cells (NG Ctrl); Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells 
with ERS blocker PBA (Pos+B); High glucose treated cells for 24 hours (HG24); High glucose 
treated cells for 24 hrs with PBA (HG24+B); High glucose treated cells for 48 hrs (HG48); High 
glucose treated cells for 48 hrs with PBA (HG48+B). 
 
 
 The gene expression of XBP1 for HRMEC treated with TM showed a significant increase 
(P=0.005) in the expression by 2.2 folds compared to the normoglycemia group. HRMEC 
of high glucose 24 hr showed a significant increase (p=0.019) by 0.95 folds compared to 
the normoglycemic group. Also, HRMEC with TM and ERS blocker PBA decreased 
significantly the level of the expression (p=0.001) by 1.45  folds compared HRMEC  with 
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TM only. In HRMEC of high glucose 24 with PBA, the reduction was significant (p= 
0.001) by  1.4 folds compared to HRMEC with high glucose only (figure 10). 
 
 
  
Figure 10. Quantitative Real time - PCR  (q-PCR) analysis of  XBP1 in HRMEC treated with 
Tunicamycin (0.1µg/mL) and high glucose concentration (30mM) for 24 and 48 hours. Bars shows 
the data presented as Mean ±SEM of 2-3 independent experiments analyzed by one-way ANOVA 
with a post-hoc test for multiple comparison tests. The two-tailed P- value is significant at p ≤0.05. 
* p≤0.05 versus the untreated control group, δp≤0.05 compared with blocked Tunicamycin group. 
Abbreviations, normoglycemic cells (NG Ctrl); Tunicamycin-treated cells (Pos Ctrl); 
Tunicamycin-treated cells with ERS blocker PBA (Pos+B); High glucose treated cells for 24 hours 
(HG24); High glucose treated cells for 24 hrs with PBA (HG24+B); High glucose treated cells for 
48 hrs (HG48); High glucose treated cells for 48 hrs with PBA (HG48+B). 
 
 
**
**
** 
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The mRNA expressions of the pro-apoptotic gene NFkB showed a significant difference 
between HRMEC exposed to high glucose for 24 and  HRMEC of normoglycemia 
(p=0.011) by 1.5 fold while HRMEC exposed to high glucose for 48 hr showed an 
insignificant increase in NFkB expression compared to normoglycemia. HRMEC treated 
with high glucose for 24 hr and with ERS inhibitor PBA showed significance decrease 
compared to HRMEC with a high glucose only group (p≤0.05) (figure 11). 
 
 
 
Figure 11. quantitative Real Time - PCR analysis of NFkB in RNA extract of HRMEC exposed high glucose level for 
24 and 48 hours and addition inhibition of ERS PBA.  Bars shows the data presented as Mean ±SEM of 2-3 independent 
experiments analyzed by one-way ANOVA with a post-hoc test for multiple comparison tests. The two-tailed P- value 
is significant at p ≤0.05. * p≤0.05 versus the untreated control group. Abbreviations, normoglycemic cells (NG Ctrl); 
Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells with ERS blocker PBA (Pos+B); High glucose treated 
cells for 24 hours (HG24); High glucose treated cells for 24 hrs with PBA (HG24+B); High glucose treated cells for 48 
hrs (HG48); High glucose treated cells for 48 hrs with PBA (HG48+B). 
**
**
** 
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The mRNA relative quantitative of VEGFA genes, which is involved in the angiogenesis, 
in HRMEC exposed to 0.1µg/mL TM revealed a significant upregulation (P= 0. 004) in 
the expression level by approximately 4 folds in comparison to normoglycemia. Also, 
HRMEC exposed to 24 and 48 hr high glucose showed significance increase (p <0.05) 
compared to normoglycemia. Likewise, the addition of ERS inhibitor PBA exhibited a 
significant difference between the treatment groups (p<0.05) (figure 12). 
 
 
 
Figure 12. quantitative Real Time -PCR analysis of VEGF-A in RNA extract of HRMEC exposed to TM, 
high glucose level for 24 and 48 hours and addition inhibition of ERS PBA.  Bars shows the data presented 
as means ±SEM of 2-3 independent experiments analyzed by ANOVA with multiple comparisons between 
individual groups. *p≤0.05 compared with the normoglycemic group. Abbreviations, normoglycemic cells 
(NG Ctrl); Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells with ERS blocker PBA (Pos+B); 
High glucose treated cells for 24 hours (HG24); High glucose treated cells for 24 hrs with PBA (HG24+B); 
High glucose treated cells for 48 hrs (HG48); High glucose treated cells for 48 hrs with PBA (HG48+B). 
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4.2.5 Analysis of Cellular resistance at different time point by ECIS (Retinal 
Barrier Function): 
 
To investigate and quantify the retinal barrier quality through assessment of the HRMEC 
proliferation using Electric Cell Impedance Sensing (ECIS) technology. The ECIS mainly 
measures the resistance between the cells which will indicate the changes in the cell to cell 
adherent or barrier function. Using HRMEC cultured cells and following glucose addition 
to the cells at 80 % confluency (30 mM) for 24 hrs as pre-treatment phase and total of 48 
hrs for analytical phase. As shown in figure 13, Resistance monitored through HRMEC 
proliferation in the pre-treatment stage shows an initial increase and late decrease at 40 
kHz in the pre-treatment phase. The results showed higher resistance in the high glucose + 
blocker treated cells in comparison to the high glucose only or TM control cells.  
Furthermore, the resistance in the high glucose + blocker treated cells significantly 
increased in the 48 h treatment phase compared to the pretreatment phase (figure 13).  In 
addition, the resistance measured in the glucose treated cells was lower than the TM control 
treated (figure 13). 
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Figure 13. Resistance monitored through HRMEC proliferation in the pre-treatment stage shows 
initial increase pointed with a black arrow and later decrease pointed with blue arrow at 40 kHz. 
Yellow: 48h – high glucose + Blocker, red: TM, light blue: 48 h – high glucose. 
 
 
This experiment was repeated, and the glucose, as well as the glucose +blocker, treated 
cells were compared to non-treated cells at 2 different time points (24 hr and 48 hr). the 
same results were obtained, as the Glucose + blockers showed higher resistance compared 
to the other groups. Moreover, its resistance was greater at 48 hr compared to 24 hr pre-
treatment phase resistance. Data not shown. 
The complex impedance of ECIS electrodes was monitored in real-time throughout the 
proliferation of HRMEC and presented as the resistance frequency of 40 kHz. The analysis 
of the pre-treatment stage showed an initial increase of the resistance accompanied by cell 
spreading and proliferation followed by a decrease in the resistance in the same stage of 
Pre-treatment phase 48 hr treatment
Time (hr)
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proliferation (due to the changes in morphology and cell size). In the treatment phase, the 
resistance of HRMEC exposed to high glucose for 24 hrs and 48 hrs showed a significant 
decrease (both p < 0.05) compared to the normoglycemic group. Also, the HRMEC treated 
with TM showed a significant reduction (p < 0.05) in the resistance compared to the 
normoglycemic group. In contrast, the addition of PBA to HRMEC treated with TM and 
high glucose concentration of 24 hrs and 48 hrs revealed significant increase (p < 0.05) in 
the resistance in comparison to the same groups without the PBA (figure 14 A and B). 
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Figure 14. Characterization of trans-electrical resistance (barrier function) of HRMEC exposed to 
different treatment: high glucose concentration (30mM) for 24 and 48 hrs, TM, and the addition of 
ERS blocker PBA. A: Resistance measurement of different treatment groups presented in a plot 
from time zero for the seeding until hr 70. B: Bars shows the significance of resistance (barrier 
function) change between the different treatment groups presented as mean and SEM. *p <0.05 
compared with the normoglycemic group. Α p<0.05 compared with TM group. πp<0.05 compared 
to high glucose of 24 hrs. δp<0.05 compared with high glucose for 48 hours. Abbreviations, 
normoglycemic cells (NG Ctrl); Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells 
with ERS blocker PBA (Pos+B); High glucose treated cells for 24 hours (HG24); High glucose 
treated cells for 24 hrs with PBA (HG24+B); High glucose treated cells for 48 hrs. (HG48); High 
glucose treated cells for 48 hrs. with PBA (HG48+B). 
 
Control
TM
TM+blocker
High G -24h
HG+blocker -24h
High G -48h
HG+blocker -48h
A 
B 
 45 
 
 
4.2.6 Analysis of Adhesion Molecules by Flowcytomery: 
 
To study the effect of ERS-induced by hyperglycemia on the cellular adhesion proteins E-
selectin and ICAM-1 in HRMEC, protein expression was measured by BD® Acuuri 
Flowcytometer. For ICAM-1, the results revealed a significant increase in ICAM-1 
expression in TM (figure 15 B), high glucose of 24 hrs ( figure 15 D) and high glucose 48 
hrs groups (figure 15 F) ( p<0.001) in comparison to normoglycemia group (figure 15 A) 
by 1.1, 1.19 and 1.77 folds respectively (figure 15 H) . The expression of ICAM-1 in 
HRMEC TM + inhibitor PBA or blocker treated cells (figure 15 C) and  24 hrs high glucose 
treated cells (figure 15 E) revealed non-significance effect in comparison to the 
normoglycemia.  
The addition of PBA inhibitor or blocker resulted in significant reduction (p<0.001)  in the 
ICAM-1 expression as combined with each treatment (e.g., the ICAM expression was 
lower in the TM+ blocker treated cells than in TM-treated HRMEC). Moreover, comparing 
high glucose group versus the high glucose with inhibitor PBA both treated for 48 hr 
showed a significant decrease (p<0.001) in ICAM-1 expression in the combined treatment 
group by 0.9 fold (figure 15 H). 
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Figure 15. ICAM-1 (CD 54) Protein expression in HRMEC exposed to different treatments: 0.1µg/mL TM, 
30 mM high glucose and inhibition of ERS PBA. Dot Plots and % of Protein expression of ICAM-1 (CD 54) 
in HRMEC exposed to different treatments: 0.1µg/mL TM, 30mM high glucose, and inhibition of ERS PBA. 
Data presented in bars shows the significance of expression change between the different treatment groups. 
*p <0.05 compared with the normoglycemic group. δ p<0.05 compared with TM group. Փp<0.05 compared 
to high glucose of 24 hours. αp<0.05 compared with high glucose for 48 hours. Abbreviations, 
normoglycemic cells (NG Ctrl); Tunicamycin-treated cells (Pos Ctrl); Tunicamycin-treated cells with ERS 
blocker PBA (Pos+B); High glucose treated cells for 24 hrs (HG24); High glucose treated cells for 24 hrs 
with PBA (HG24+B); High glucose treated cells for 48 hrs (HG48); High glucose treated cells for 48 hrs 
with PBA (HG48+B). 
A B C
D E F
G
H
A      B     C      D      E      F     G
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Similar to ICAM-1 expression results, E-selectin exhibited similar results. HRMEC treated 
with 24 hrs high glucose and treated with 48 hrs high glucose showed a significant increase 
(p=0.001) in comparison to normoglycemia. The expression of E-selectin for 24 hrs high 
glucose group versus HRMEC, 24 high glucose with PBA inhibitor group, revealed 
significant decrease (p=0.001) by 0.78 folds. In addition, HRMEC with 48 hrs high glucose 
group revealed significant decrease (p=0.001) compared to HRMEC with 48 hrs high 
glucose with PBA inhibitor by 0.88 fold (Figure 16). 
 
 
 
Figure 16. Protein expression of E-selectin (CD 62E) in HRMEC exposed to different treatments: 0.1µg/mL TM, 30mM 
high glucose, and inhibition of ERS PBA. Data presented in bars shows the expression change between the different 
treatment groups. *p <0.05 compared with the normoglycemic group. Փp<0.05 compared to high glucose of 24 hours. 
αp<0.05 compared with high glucose for 48 hours. Abbreviations, normoglycemic cells (NG Ctrl); Tunicamycin-treated 
cells (Pos Ctrl); Tunicamycin-treated cells with ERS blocker PBA (Pos+B); High glucose treated cells for 24 hours 
(HG24); High glucose treated cells for 24 hrs with PBA (HG24+B); High glucose treated cells for 48 hrs (HG48); High 
glucose treated cells for 48 hrs with PBA (HG48+B)
E-selectin 
 
  
5. Chapter Five  
5.1 Discussion: 
 
Angiogenesis is a process of new blood vessels formation normally occurs in the 
embryonic development and other normal physiologic processes. It is also involved in 
pathologic processes like cancer and diabetes. In diabetic retinopathy mainly the new 
retinal blood vessels are formed (retinal neovascularization) due to increasing glucose 
level in the blood which leads to blindness at the end stage of the disease. Many proposed 
mechanisms underlie the retinal blood vessels dysfunction are widely investigated yet 
poorly understood. This is because of the effect of several common signaling pathways 
interfering in the pathogenesis of the disease. One of the novels known pathways is the 
ERS  signaling pathway which is activated by the UPR. In an attempt to get a clear 
understanding of the underlying mechanism implicating in the retinal neovascularization 
and the angiogenesis pathophysiology, the current study assessed the consequences of 
hyperglycemia exposure in HRMEC on the activation of the endoplasmic reticulum stress 
pathways and its impact in regulating the inflammatory, apoptotic and the cellular 
adhesion interactions in vitro utilizing HREMC. The current study revealed major 
findings that may contribute to understanding the role of ERS in the early changes of the 
angiogenesis produced by short exposure of hyperglycemia (24 and 48 hrs) on HRMEC. 
We demonstrated that expression of the ERS genes; HSPA5, XBP1, and EIF2K3 are 
upregulated in response to hyperglycemia and decreased after ER blocker. Also, we 
noticed a significant elevation in VEGF-A, NFKB expression in response to the 
hyperglycemia with upregulation of the adhesion proteins ICAM-1and E-selectin, which 
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parallel the changes in the barrier function. Moreover, there is a significant increase in the 
oxidative stress and apoptosis in cultured HRMEC exposed to hyperglycemia. These 
findings are discussed in the next paragraphs to highlight the importance and relations to 
the observed barrier dysfunction in culture HREMC in response to high glucose and 
treatment with the ERS block (PBA). 
5.1.1 The apoptosis rate and ROS production: 
 
Apoptosis is initiated through intrinsic and extrinsic pathway as well as the reporter ERS 
associated apoptosis. Several studies reported that the UPR activation can regain the 
homeostasis of cells under mild ERS. Perpetuation ERS leads to retinal cell death which 
is a mark in the pathogenesis of DR (Zhang et al., 2014). In this study, we found a 
significant increase in the apoptotic rate and ROS production which is agreement with 
previous studies that reported the association of ERS with induction of apoptosis (Urra 
et al., 2013). In vivo study on the diabetic animal, retina suggested an elevation in the 
number of retinal neuronal cells death as well as increase ROS production when exposed 
to high glucose level (Gaspar et al., 2013). Another experimental study used different 
glucose concentrations on diabetic animal and cultured HRCEC showed a significant 
elevation in the apoptotic cells with the variable glucose used (Li et al., 2011). 
Furthermore, another study on suggested an involvement of ERS in retinal cell death 
upon administration of TM in cultured retinal ganglion cells (RCG2) (Shimazawa et al., 
2007). Ikesugi et al., 2006 reported that apoptosis was induced in pericytes exposed to 
different glucose concentrations ( Ikesugi et al., 2006). Furthermore, the significant 
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increase in ROS produced in HREMC in the present study in response to high glucose 
could be due to change in the redox status (Hwang et al., 1992). However, other studies 
suggested the participation of ERS pathway in overproduction of ROS in cells exposed 
to high glucose, which parallel the findings of the current study (Jing, Wang & Zhang, 
2012). 
5.1.2 ERS genes HSPA5, XBP1 and EIF2Ak3 in response to hyperglycemia for 24 
and 48 hours: 
 
The present study demonstrates a significant increase in the expression of ERS genes; 
HSPA5, XBP1, and EIF2Ak3 in the HRMEC exposed to 24 hours hyperglycemia. 
Previous studies showed the role of HSPA5 as a key regulator for three ERS sensors 
where it is dissociated during initial ERS.  Nakamura et al. suggested HSPA5 role in the 
abnormal vascular changes by reporting upregulation of HSPA5 gene in HRMEC 
exposed to 10ng/mL of TM (Nakamura et al., 2013). Another study performed on retinal 
pigment epithelium (RPE) of diabetic subjects reported that HSPA5 expression is 
upregulated (Du et al., 2013), which parallel the current findings. Notably, other studies 
disagreed on this gene and indicated that HSPA5 expression on HRCEC and retinal 
pericytes (Li, 2011 & Ikesugi et al., 2009 respectively) did not increase. EIF2AK3 gene 
implicated in the part of the pathway through IRE1. This pathway involved in the 
inflammation and apoptosis. In Lakshmanan et al. study reported in diabetic rat model 
eIF2 increased in myocardial cells (Lakshmanan et al., 2013). The results of the present 
study parallel this study. This is also causing downstream genes to increase like CHOP 
the pro-apoptotic marker. Furthermore, knockdown of PERK in cardiomyocytes showed 
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a strong protective effect on apoptosis induced by hyperglycemia (Liu et al., 2013).  
XBP1 is reported in preceding studies as the gene from IRE1 pathway with an 
inflammatory, and a cell survival role, where the induction of XBP1 helps induction of 
ER other chaperones that maintaining the homeostasis (Jing, Wang & Zhang, 2012). 
Several studies reported that deficiency of XBP1 leads to increase oxidative stress and 
apoptosis (Jing, Wang & Zhang, 2012). In the same study, it was suggested that 
overexpression of XBP1 is linked to downregulation of the adhesion molecules ICAM-1 
(Jing, Wang & Zhang, 2012). 
5.1.3 Angiogenic gene VEGFA, and pro-apoptotic/pro-inflammatory NFκB, 
analysis: 
 
The current study demonstrated that the angiogenic gene VEGFA expression is 
significantly increased in HRMEC exposed to 24h and 48 hours of high glucose and its 
decrease after application of the ER blocker; PBA. In addition, the treatment of HRMEC 
with 0.1µg/mL TM-induced significant increase in the expression of VEGFA. A study 
by Nakamura et al., 2013 that there was no change observed in VEGFA in response to 
TM treatment (Nakamura et al. 2013). Another study reported overexpression of VEGFA 
in HREC and Akita mice model suggesting its role in the retinal inflammation and 
angiogenesis (Li et al., 2009).  Alternatively, another study aiming to study diabetic 
retinopathy at an early stage reported an increase in VEGFA expression in diabetic model 
versus control one (Li et al., 2011). The data of the current study is in agreement with 
these previous studies (Li et al., 2009), and (Li et al., 2011). The pro-inflammatory gene 
NFkB showed significance increase in the mRNA expression level for HRMEC exposed 
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with high glucose for 24 and 48 hours. The results of this study are in agreement with 
previous studies (Ornoy et al. 2010) and (Popov 2010). Many studies reported that NFkB 
could be regulated through the three ERS sensors which mean that three sensors 
participate in the inflammatory role (Hotamisligil, 2010). 
5.1.4 Hyperglycemia increase adhesion proteins ICAM-1 and E-selectin: 
 
Adhesion molecules are cell surface proteins that help cells to interact with each other. 
In the current study, exposure of HRMEC to high glucose upregulates ICAM-1 and E-
selectin.  Increased adhesion molecules reported causing vascular leakage which also 
reduce the retinal barrier leading to the main pathogenesis hallmark of DR.  A study by 
Jingming, demonstrated that in HREC treated with 0.1µg/mL TM and followed by TNF-
α treatment exhibited reduced ICAM-1 protein level.  This study also suggested that the 
type of the chemical inducer used could affect the result of the adhesion molecules. Lie 
et al.; 2011 compared both TM and Thapsigargin as inducer where TM reduced ICAM-
1 and the Thapsigargin increased the ICAM-1 level.(Li et al. 2011) Also, another study 
reported an increase in ICAM-1 protein level in rat retinal capillary EC line exposed to 
25mmol of glucose (Zhang et al., 2015). ICAM-1 was reported in several studies as to be 
induced by several other markers like induction of VEGFA and TNF-α (Ehrich et al., 
2010). However, our result suggests that the increase could be as a consequence of the 
collective effect of other pathways inducing the expression of ICAM-1 and E-selectin 
proteins.  
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5.1.5 Barrier quality of HRMEC were reduced by the effect of hyperglycemia: 
  
Disturbance of blood retinal barrier induced by hyperglycemia lead to changes in the 
retinal vessels and exposure of the retina to the inner luminal vessels. In this study the 
assessment of barrier function was performed by ECIS which is permitting the real time 
and continuous monitoring of HRMEC during proliferation and treatment. In this study 
ECIS revealed that the HRMEC cell resistance (barrier quality) significantly decreased 
in the monolayer cells exposed to 24 and 48 hours high glucose compared to normal 
control. This could explain the effects of hyperglycemia on HRMEC and also supporting 
the result of increase expression of ICAM-1 and E-selectin proteins. The  current data is 
supported by a previous study by Hussein et al 2014 that the  barrier function was 
decreased in BREC of diabetic model animal after 2 hours treatment (Hussein, et al. 
2014) and in culture HRMEC in response to high glucose (Rizk, et al. 2014). 
5.1.6 Effect of 4-phenybutyric acid (PBA) as an inhibitor of ERS: 
 
In this study, PBA was used as ER blocker as previously published  (Li, et al. 2009). 
Results of apoptosis and ROS indicated a significant reduction in PBA treated HRMEC. 
Also, the significant reduction was noted in the adhesion proteins (ICAM and E-selectin), 
and in the improvement of the HRMEC barrier function. Overall, the reduction in ERS 
marker HSPA5, EIF2Ak3, XBP1, and pro-inflammatory NFκB and the angiogenic 
VEGFA biomarkers could refer to the role played by ERS in induction of the barrier 
dysfunction in retinal endothelial cells through its effects on ERS genes and its 
consequence on inflammatory, angiogenic, apoptotic and oxidative stress pathways. This 
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consistent with a previous study where PBA reported to be administered one hour before 
the treatment and decreased ICAM-1, TNF and VEGF retinal cell EC (Chen et al, 2012). 
In addition, PBA is an approved drug by FDA used in the treatment of urea-cycle 
disorder. We propose that cells exposed to hyperglycemia induces ERS as evident by 
upregulation of HSPA5, EIF2Ak3, XBP1with subsequent increase in ROS, apoptosis and 
VEGFA with marked effects of the barrier function associated with the upregulation of 
ICAM and p- selectin and subsequent decreased in these adhesion markers with 
corresponding improvement in the barrier function by ER blocker. 
5.2 Conclusion: 
 
In conclusion, our data suggest that glucose concentration of 30mM induced apoptosis 
and oxidative stress through the ERS which is the proposed mechanism pathway. ERS 
induced loss of barrier function in HRMEC by increasing the expression of ICAM-1 and 
E-selectin. Understanding the downstream of ERS pathway could support the current 
result that ERS is involved in the angiogenesis of DR. This study is limited by lack of in 
vivo experiments using diabetic animal models and also studying the protein expressions 
of ERS markers. 
5.3 Future Direction: 
 
The result of this study delivered valuable data related to ERS role in the retinal 
endothelial cells at an early stage of high glucose exposure. However, further studies are 
needed to clarify other ERS pathway expression genes. This study did not include the 
protein expression of ERS (e.g.CHOP and ATF4) as well as tight junction molecules 
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(e.g.Occludin). These proteins could provide a better understanding for the role of the 
downstream pathway genes in the retinal blood barrier breakdown and vascular 
permeability. Also, long term high glucose exposure could be studied in the same type 
of cells in the context of this study emphasizing on the complications of hyperglycemia 
on the retina. 
In addition, the study can be expanded to include future investigation of  in-vivo animal 
model to explore the ER role in details and  . The success of such study can open the 
doors to investigate the ERS role in diabetic patients as clinical trials. 
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سطة ارتفاع السكر في الدم على وظيفة الحاجز في الخلايا ابو تـاثير اجهاد الشبكة الاندوبلازمية
 البطانية الشبكية
  
تحتفظ الدول العربية بصدارة اكثر الدول  .المزمنة والمنتشرة بكثرة في هذا العصر من الامراض يعتبر داء السكري
لمرض السكري مضاعفات عديدة اهمها هو اعتلال شبكية   .المصابة بالسكري حسب احصائيات منظمة الصحة العالمية
لشبكية هو خلل في تكوينات الحواجز الدموية ان من اهم اسباب اعتلال ا العين المصاحب لارتفاع الجلوكوز بالدم. يعتقد
 .للشبكية ومضاعفات التهابية
هناك عدة آليات على مستوى الخليه لحدوث اعتلال الشبكية. احدث هذه الآليات هو اجهاد الشبكة الاندوبلامية. حيث 
 تكمن اهمية الشبكةتصاب الشبكة الاندوبلازمية بالخلل في وظائفها العادية نتيجة تراكم الغلوكوز في الدم. و
البروتينات في الخلية وعند حدوث اي خلل يؤدي هذا الى تراكم البروتين  الاندوبلازمية في انها تعتبر المصنع لجميع 
الغير مكتمل التصنيع وبالتالي خلل الوظائف المترتبة على هذه البروتينات. وفي حالة استمرار هذا الاجهاد يؤدي هذا 
المتعرضة للجلوكوز لفترات طويلة. هذه الآالية يعتقد ايضا انها مربطة بامراض اخرى بالاضافة الى  الخلايا الى موت
 السكري مثل السرطان و بعض الامراض العصبية. 
في هذا البحث اعمل على فرضية ان اجهاد الشبكة الاندوبلازمية مرتبط تحديدا باعتلال الشبكية من خلال افراز الشبكة 
 laniterلبعض لعوامل التي تؤدي الى خلل في ترابط وتكوين الخلايا المبطنة للشعيرات الدموية للعين ( الاندوبلازمية
). . وحيث ان هناك دراسات اثبتت وجود مستحضرات كيميائية ممكن ان تعاكس اجهاد الشبكة sllec lailehtodne
سوف يستخدم ايضا في هذا   dica cirytublynehpالاندوبلامية من خلال منعها او تقليلها، فان هذا المستحضر وهو 
 البحث. 
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المميز في هذا البحث ان الية للشبكة الادوبلازمية درست على نطاق واسع في معظم انواع خلايا العين ماعدا الخلايا 
بكية شالمبطنة للشبكية. ونأمل بان تسهم نتائج هذا لبحث في فهم اعمق لهذه الآلية ومساعدة مرضى السكري واعتلال ال
 .بعلاج مناسب في المستقبل
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Appendix C.  Research Poster:  
       An oral presentation for the study was  performed during the Fifth research forum 
conducted at Hamad Medical Corporation 26th May 2016. 
 
